BioSpace News Archive

Sharp brings a wealth of experience in financial management and corporate strategy in rare disease, gene therapy and oncology.

ASN008 is a topical gel for the treatment of pruritus (itch) associated with atopic dermatitis.

Combination to create a comprehensive cataract product portfolio and expand footprint into new and existing markets

Adaptation Health in partnership with the Center for Health Care Strategies has been invited by the Director of the Arizona Health Care Cost Containment System (AHCCCS)–Arizona’s single-state Medicaid system, to organize and deliver a Medicaid Innovation Challenge on March 29, 2019 in Phoenix, Arizona.

Collaboration leverages strengths to advance the progress of intrathecal therapies to treat severe neurological conditions

Xeris Pharmaceuticals, Inc. (Nasdaq: XERS), a specialty pharmaceutical company leveraging its novel technology platforms to develop and commercialize ready-to-use injectable and infusible drug formulations, announced today that it has received Orphan Medicinal Product designation from the European Medicines Agency

Committee is Comprised of World Leaders in IgA Nephropathy and Renal Clinical Research

Licensing agreement includes equity investment and potential development, clinical, regulatory and commercial milestones and tiered royalties

Shareholders should expect to receive the company’s proxy statement and related materials in early January 2019.

Medical Marijuana, Inc. (OTC: MJNA), the first publicly traded cannabis company in the United States, today announced that it has garnered news coverage on the top national financial news network CNBC.